Literature DB >> 17347691

Acetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth noting.

Michael R Buchanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17347691      PMCID： PMC2647868          DOI： 10.1016/s0828-282x(07)70745-6

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  10 in total

1.  Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.

Authors:  Robert S Poston; Junyan Gu; James M Brown; James S Gammie; Charles White; Lei Nie; Richard N Pierson; Bartley P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  2005-12-09       Impact factor: 5.209

2.  [Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention].

Authors:  Yan Zhang; Jing Liang; Yu-jie Zhou; Hui Yuan; Yong-zhi Zhang; Lei Dong
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2005-08

3.  Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.

Authors:  Andrew L Frelinger; Mark I Furman; Matthew D Linden; Youfu Li; Marsha L Fox; Marc R Barnard; Alan D Michelson
Journal:  Circulation       Date:  2006-06-19       Impact factor: 29.690

4.  Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.

Authors:  Kjell Andersen; Mette Hurlen; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb Res       Date:  2002-10-01       Impact factor: 3.944

5.  Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.

Authors:  Mehmet Birhan Yilmaz; Yucel Balbay; Vedat Caldir; Selime Ayaz; Yesim Guray; Umit Guray; Sule Korkmaz
Journal:  Thromb Res       Date:  2005       Impact factor: 3.944

6.  [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].

Authors:  D Stejskal; J Prosková; B Lacnák; D Horalík; A Hamplová; I Oral; I Hrabovská; R Ochmanová; S Adamovská; R Juráková; G Ozanová; J Juchelka; O Kulísková; H Pĕnkavová
Journal:  Vnitr Lek       Date:  2004-08

7.  Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients.

Authors:  K H Grotemeyer; H W Scharafinski; I W Husstedt
Journal:  Thromb Res       Date:  1993-09-01       Impact factor: 3.944

8.  Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.

Authors:  Wai-Hong Chen; Pui-Yin Lee; William Ng; Hung-Fat Tse; Chu-Pak Lau
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

9.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

Authors:  Patricia A Gum; Kandice Kottke-Marchant; Patricia A Welsh; Jennifer White; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

10.  Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically.

Authors:  M R Buchanan; S J Brister
Journal:  Can J Cardiol       Date:  1995-03       Impact factor: 5.223
  10 in total
  1 in total

1.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.